Chemotherapy in elderly patients with bronchogenic carcinoma;Chimiotherapie des cancers bronchiques des sujets ages

Revue des Maladies Respiratoires

Volumn 13, Issue 4, 1996, Pages 327-333

  Souquet, P J ^a   Lombard Bohas, C H ^a   Freyer, G ^b   Bombaron, P ^a   Geriniere L ^a   Bernard, J P ^a  

^a Service de Pneumologie   (France)

^b Centre L Berard   (France)

Author keywords

age; chemotherapy; efficacy; old people; toxicity

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT;

AGED; AGING; DRUG EFFICACY; DRUG TOXICITY; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; NEPHROTOXICITY; NEUROPATHY; QUALITY OF LIFE; REVIEW; EPIDEMIOLOGY; FEMALE; LONGEVITY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METHODOLOGY; PATIENT SELECTION; PROGNOSIS; RETROSPECTIVE STUDY; SMALL CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIAS (EPIDEMIOLOGY); CARCINOMA, BRONCHOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; HUMANS; LONGEVITY; LUNG NEOPLASMS; MALE; PATIENT SELECTION; PROGNOSIS; QUALITY OF LIFE; RESEARCH DESIGN; RETROSPECTIVE STUDIES;

EID: 0029684086     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. SPENCER G : Projection of the population of the United States by age, sex and race, 1988-2080, Bureau of the census-current population reports, series P25 no1018, Washington, DC : US Government Printing Office, 1989.
2. MULLER BA, RIES LAG, HANKEY BF, KOSARY CC, EDWARDS BK : Surveillance, epidemiology and end resultsprogram. National Institutes of Health 1993, oct, NIH Report no94-3074.
3. SAMET J, HUNT WC, KEY C, HUMBLE CG, GOODWIN JS : Choice of cancer therapy varies with age of patient, JAMA 1986;2245:3385-90.
4. NEWCOMBE PA, CARBONE PP : Cancer treatment and age : patients perspective. J Natl Cancer Instit 1993;85:1580-4.
5. COHEN HJ : Biology of aging as related to cancer. Cancer 1994;74:2092-100.
6. TEETER SM, HOLMES FF, MCFARLANE MJ : Lung carcinoma in the elderly population : influence of histology on the inverse relationship of stage to age. Cancer 1987;60:1331-96.
7. O'ROURKE MA, FEUSSNER JR, FEIGL P, LASZLO J : Age trends of lung cancer stage at diagnosis : implications for lung cancer screening in elderly. JAMA 1987;258:921-6.
8. GOODWIN JS, SAMET JM, KEY CR : Stage at diagnosis of cancer varies with the age of patients. J Am Geriatr Soc 1986;34:20-6.
9. MCKENNA RJ : Clinical aspects of cancer in the elderly : treatment decisions, treatment choices and follow up. Cancer 1994;74:2107-17.
10. WALSH SJ, BEGG CJ, CARBONE P : Cancer chemotherapy in the elderly. Seminars in Oncology 1989;16:66-75.
11. ANDERSON S, BRENNER BM : Effects of aging on the renal glomerulus. Am J Med 1986;80:435-42.
12. COCKROFT DW, GAULT MN : Prediction of creatinine clearance from serum creatinine, Nephron 1976;16:31-41.
13. HRUSHESKI W, SHIMP W, KENNEDY BJ : Lack of age-dependent cisplatin nephrotoxicity. Am J Med 1984;76:579-84.
14. BALDUCCI L, PARKER M, SEXTON W, TRANTANOND P : Pharmacology of antineoplastic agents in the elderly patients. Seminars in Oncology 1989;16:76-84.
15. THISS A, SAUDES L, CREISSON A, DASSONVILLE O, SCHNEIDER M : Renal tolerance of cisplatin in patients more than 80 years old. J Clin Oncol 1994;12:2121-5.
16. DESOIZE B : A quel critère faut-il adapter la posologie des anticancéreux. Bull Cancer 1993;80:376-90.
17. YAMAMOTO N, TUMINA T, MOREDA M : The influence of ageing on CDDP pharmacokinetics in lung cancer patients with normal organ function. Cancer Chemother Pharmacol 1995;36:2,102-6.
18. CALVERT HA, NEWELL DR, GUMBRELL LA O'REILLY S, BURNELL M, BOXALL FE, SIDDICK ZH, JUDSON IR, WILTSHAW E : Carboplatin dosage : prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989;7:169-80.
19. BUZDAR AV, MARCUS C, SMITH TL, BLUMENSCHEIN GP : Early and delayed clinical toxicity of doxorubicin. Cancer 1985;55:2761-5.
20. BERETTA G, CRESSOTI A, BRASCHI GL, BOLLINA R, BRAMBILKLA GF, COVA D : Acute cardiotoxicity of 4′ epidoxorubicin (EPI) in adults and elderly patients. Proceedings ASCO 1993;12(abstract):443.
21. BALDUCCI L, WALLACE C, KHAUSUR T : Nutrition, cancer and aging. J Am Geriatr Soc 1986;34:127-36.
22. PHISTER JE, JUE SG, CUSACK BJ : Problems in the use of anticancer grungs in the elderly. Drugs 1989;37:5519-65.
23. BALIS FM : Pharmacokinetic drug interaction of commonly used anticancer drugs. Clin Pharmacokinet 1987;13:205-27.
24. BROOKS B, GRALLA R, CLARK RA, TYSON LB, BALTZER L, KRIS MG : Are serotonin antagonist anti-emetic safe and effective in older patients receiving cisplastin. Proceedings ASCO 1993;12(abstract):1610.
25. KENNARD D, BUTCHER M, PALMER J : The anti-emetic efficacy pharmacokinetics and safety to ondansetron in the elderly receiving cancer chemotherapy or radiotherapy. Ondansetron Satellite Symposium of UICC, Hamburg, 1992.
26. MCMILLAN S : Intensity of pain nausea and vomiting in relationship to age in persons with cancer. In : Balducci et al. (eds), Geriatric Oncology. JB Lippincott, 1992.
27. PETRILLI N, STABLEIN D, BRUCKNER A, MEGIBOW A, MAYER R, DOUGLASS H : A prospective randomised phase III trial of 5 FU versus 5 FU+high dose leucoverin versus 5 FU+low dose leucoverin in patients with metastatic colorectal adenocarcinoma. Proceedings ASCO 1988;7(abstract):357.
28. HOAGLAND HC : Hematologic complication of cancer chemotherapy. Seminars in Oncology 1982;9:95-102.
29. BEGG CB, ELSON PJ, CARBONE PP : A study of excess hematologic toxicity in elderly patients treated on cancer chemotherapy protocols. In : Yancik R, ed. Cancer in the elderly. Approach to early detection and treatment. Springer Verlag, 1989.
30. SHANK WA, BALDUCCI L : Recombinate hematopoietic growth factors : comparative hematopoietic response in younger and older subjects. J Am Geriatric Soc 1993;40:151-3.
31. GINSBERT SJ, COMIS RL : The pulmonary toxicity of antineoplastic agents. Seminars in Oncology 1982;9:34-51.
32. GIOVANAZZI-BANNON S, RADEMAKER A, LAI G, BENSON III AIB : Treatment tolerance of elderly cancer patients entered onto phase II clinical trials : an Illinois Cancer Center study. J Clin Oncol 1994;12:2447-52.
33. BEGG CB, CARBONE PP : Clinical trials and drug toxicity in the elderly : the experience of the ECOG. Cancer 1983;52:1986-92.
34. CHAUVERGNE J, HOERNI B, MALET M : Traitement des cancéreux âgés. Actualités cancérologiques. Sem Hôp Paris 1984;60:1217-26.
35. SHEPERD FA, EVANS WK, GOSS PE : Treatment of small cell lung cancer in the elderly. 6thWorld Conference on Lung Cancer. IASLC, Melbourne, 10-14/11,1991:A388.
36. KELLY P, O'BRIEN AA, DALY P : Small cell lung cancer in elderly patients : the case for chemotherapy. Age-Ageing 1991;20:19-22.
37. GOSS GD, LOGAN D, MAROUN J, STEWART D, YAU J, EVANS WK : Chemotherapy in elderly patients with small cell lung cancer ? Proceedings ASCO 11/03/92;(abstract):969.
38. POPLIN E, THOMPSON, B, WHITACRE M, AISNER J : Small cell carcinoma of the lung : influence of age on treatment outcome. Cancer Treat Rep 1987;71:291-96.
39. SLEVIN ML, CLARK PI, JOEL SP : A randomised trial to evaluate the effect of schedule on the activity of Etoposide in small cell lung cancer. J Clin Oncol 1989;7:1333-40.
40. CARNEY DN, GROGAN L, SMIT EF, HARFORD P, BERENDSEN HH, POSTMUS PE : Single agent oral etoposide for elderly small cell lung cancer patients. Seminars in Oncology 1990;17(suppl.2):43s-53s.
41. SMIT EF, CARNEY DN, HARFORD P, SLEIDJER DT, POSTMUS PE : A phase II study of oral etoposide in elderly patients with small cell lung cancer. Thorax 1989;44:631-3.
42. JOHNSON DH : Treatment of the elderly patient with small cell lung cancer. Chest 1993;103(supll.):72-4s.
43. BYRNE A, CARNEY DN : Small cell lung cancer in the elderly. Seminars in Oncology 1994;21(suppl.6):43-8s.
44. TUMARELLO D, ISIDORI P, PASINI F, CETTO G, CELLERINO R : Teniposide as single drug therapy for elderly patients affected by small cell lung cancer. Eur J Cancer 1992;28:1081-4.
45. HOSMIDIS P, SAMANTAS E, FOUNTZILAS G, PAVLIDIS N, APOSTOLOPOULOU F, SKARLOS D, FOR THE HECOG : Cisplatin/etoposide versus carboplatin/etoposide chemiotherapy and irradiation in small cell lung cancer : a randomised phase III study. Seminars in Oncology 1994;3(suppl.6):23-30.
46. CARNEY D : Carboplatin/etoposide combination chemotherapy in the treatment of poor prognosis patients with small cell lung cancer. Lung Cancer 1995;12(suppl.3):S77-83.
47. LESLIE W, BONOMI P, HALE M : Combined modality therapy for stage III non small cell lung cancer : comparison of geriatric and younger patients. Proceedings ASCO 1991;10(abstract):876.
48. RINALDI M, DE MARINIS F, ARDIZZONI A, PENNUCCI MC, BRUZZI P, SALVATI F, PORTALONE L, SORESI E, FIGOLI F, VERONESI A, SCAGLIOTI G, PACCAGNELLA A, FUSCO V, FIORENTINI G : Correlation between age and prognosis in patients with advanced non small cell lung cancer treated with cisplatin containing chemotherapy : a retrospective multicenter study. Annals of Oncology 1994;5(suppl.8)abstract:288.
49. KUBOTA K, FURUSE K, KAWAHARA M, KODAMA N, OGAWARA M, FUKUOKA M, TAKADA M, MASUDA M, NEGORO S : Combination chemotherapy for elderly patients with non small cell lung cancer. Proceedings ASCO 1994;13(abstract):1163.
50. GALLOTTI P, CHIESA E, OLGIATI A, BOTTARO G, NATALE G, FREDDI E : Vindesine as monochemotherapy non small cell lung cancer. Annals of Oncology 1992;3(supll.5)(abstract):142.
51. MANENTE P, COLLEONI M, GAION F, SGARBOSSA G, NELLI P : Vinorelbine in elderly patients with advanced non small cell lung cancer. Annals of Oncology 1994;5(suppl.8)(abstract):294.
52. ARDIZZONI A, MARTIN C : Gemcitabine toxicity profile and efficacy unaffected by age in advanced non small cell lung cancer. Annals of Oncology 1994;5(suppl.8)(abstract):296.
53. NAKAMURA E, MIYAO K, OZEKI T : Assessment of biological age by principal component analysis. Mech Ageing Dev 1988;46:1-18.
54. FREYER G : Chimiothérapie cytotoxique et sujets âgés : constats et perspectives. Bulletin du Cancer 1995; (à paraître).
55. YELLEN SB, CELLA DF, LESLIE WT : Age and clinical decision making in oncology patients. J Nat Cancer Inst 1994;86:1766-70.